Atossa Genetics Common Stock Net 2012-2025 | ATOS
Atossa Genetics common stock net from 2012 to 2025. Common stock net can be defined as the value of common equity ownership.
| Atossa Genetics Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $23 |
| 2023 | $23 |
| 2022 | $23 |
| 2021 | $23 |
| 2020 | $9 |
| 2019 | $2 |
| 2018 | $1 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| Atossa Genetics Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-06-30 | $23 |
| 2025-03-31 | $23 |
| 2024-12-31 | $23 |
| 2024-09-30 | $23 |
| 2024-06-30 | $23 |
| 2024-03-31 | $23 |
| 2023-12-31 | $23 |
| 2023-09-30 | $23 |
| 2023-06-30 | $23 |
| 2023-03-31 | $23 |
| 2022-12-31 | $23 |
| 2022-09-30 | $23 |
| 2022-06-30 | $23 |
| 2022-03-31 | $23 |
| 2021-12-31 | $23 |
| 2021-09-30 | $23 |
| 2021-06-30 | $23 |
| 2021-03-31 | $22 |
| 2020-12-31 | $9 |
| 2020-09-30 | $2 |
| 2020-06-30 | $2 |
| 2020-03-31 | $2 |
| 2019-12-31 | $2 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $2 |
| 2018-12-31 | $1 |
| 2018-09-30 | $1 |
| 2018-06-30 | $1 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.101B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.157B | 22.16 |
| Intuitive Surgical (ISRG) | United States | $171.022B | 70.89 |
| IDEXX Laboratories (IDXX) | United States | $52.319B | 54.45 |
| Edwards Lifesciences (EW) | United States | $45.899B | 30.42 |
| Alcon (ALC) | Switzerland | $42.809B | 28.93 |
| IQVIA Holdings (IQV) | United States | $32.198B | 18.19 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.060B | 32.12 |
| STERIS (STE) | Ireland | $24.242B | 25.80 |
| Waters (WAT) | United States | $17.472B | 24.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.672B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.441B | 26.82 |
| Masimo (MASI) | United States | $8.250B | 27.76 |
| Globus Medical (GMED) | United States | $8.125B | 18.70 |
| Teleflex (TFX) | United States | $5.369B | 8.67 |
| Glaukos (GKOS) | United States | $5.223B | 0.00 |
| TransMedics (TMDX) | United States | $4.423B | 67.22 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.956B | 16.92 |
| Veracyte (VCYT) | United States | $2.363B | 32.65 |
| Alphatec Holdings (ATEC) | United States | $2.304B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.232B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.046B | 24.43 |
| Artivion (AORT) | United States | $2.027B | 102.26 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Pulse Biosciences (PLSE) | United States | $1.165B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.061B | 6.08 |
| IRadimed (IRMD) | United States | $0.892B | 43.30 |
| Beta Bionics (BBNX) | United States | $0.726B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.720B | 0.00 |
| AxoGen (AXGN) | United States | $0.686B | 0.00 |
| SiBone (SIBN) | United States | $0.660B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.549B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.520B | 4.18 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.509B | 8.98 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.50 |
| Pacific Biosciences Of California (PACB) | United States | $0.369B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 87.25 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| RxSight (RXST) | United States | $0.336B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.276B | 19.05 |
| Alpha Tau Medical (DRTS) | Israel | $0.271B | 0.00 |
| 908 Devices (MASS) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.235B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.207B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.092B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.16 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |